I am glad i sold out on Monday, wished i had read between the lines earlier to know that the science is not as good as they promote. Being someone who doesn't understand the science and probability of success means i should have looked at what management and directors are doing, not what they are saying. Buying Azercell was diversion tactic because the other drugs like B cell are not as good as hyped. Insider selling and lack of buying also should have told me to get out earlier. A lack of transparency on the deprioritising of PD1Vaxx and Hervaxx was another sign. I will consider getting back in after CR if results show promise and insiders start buying.
IMU Price at posting:
4.4¢ Sentiment: Sell Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)